Machupo virus (MACV) is a New World (NW) arenavirus and causative agent of Bolivian hemorrhagic fever (HF).
. The L-segment encodes the matrix ring finger Z protein 4 and the polymerase L protein (L-segment) 5 . The S-segment encodes the nucleoprotein (NP) and the glycoprotein precursor (GPC) 6 . GPC is cleaved into two glycoproteins, GP1 and GP2 by the cellular protease S1P 7 . Each RNA segment encodes two ORFs and also contains noncoding regions including 5′ and 3′ untranslated regions (UTRs) and a non-coding intergenic region (IGR) 3, 8, 9 . Mammalian arenaviruses (genus mammarenavirus) are divided into the Old World (OW) and New World (NW) complexes based on geographical distribution and serology 2 . Machupo virus (MACV) is a member of the NW complex of arenaviruses and is the causative agent of Bolivian hemorrhagic fever (HF) 2 . Human infections generally result from exposure to chronically infected rodents (Calomys callosus) 10 , but human-to-human spread has been reported 11 . Bolivian HF is a febrile illness often associated with vascular leakage and occasional concomitant neurological manifestations 11, 12 . Infection can result in a systemic inflammatory response syndrome leading to multiple organ failure and death. Other NW arenaviruses, including Junin virus (JUNV) and Guanarito virus (GTOV), also cause HF in South America 2, 13 . More recently other NW arenaviruses capable of causing human disease have emerged, including Sabia virus, Chapare virus and Whitewater Arroyo virus 2, [13] [14] [15] [16] . Therefore, this family of viruses is an important group of emerging and re-emerging human pathogens.
No FDA licensed countermeasures exist to treat NW arenaviruses. Active and passive vaccine strategies, as well as small molecule inhibitors have been shown to be effective at reducing lethality in humans [17] [18] [19] . An attenuated live-virus vaccine, termed Candid#1, is currently used in populations at high risk to JUNV infection in Argentina [20] [21] [22] [23] . Implementation of this vaccine in endemic regions reduced fatality rates substantially.
Some evidence based on studies in guinea pigs and non-human primates (NHPs) suggest that Candid#1 can cross-protect against MACV 24 ; however, these findings have not been validated in humans. Candid#1 was produced by passage of the virulent XJ strain twice in guinea pigs, 44 times in mouse brains and finally several passages in fetal rhesus lung diploid cells (FRhL-2) 23, [25] [26] [27] . This process produced a strain attenuated in humans, non-human primates, guinea pigs, and mice that also lacked neurotropism in animal models. The exact nature of the attenuation is enigmatic and recent evidence suggests that a single amino acid change in the GP2 transmembrane region restores virulence in neonatal mice 25 . Other NW arenavirus vaccine strategies have included the use of Tacaribe virus (TACV), an arenavirus serologically related to JUNV and MACV believed to be apathogenic in humans. In animal models, TACV functions as a vaccine against JUNV 28, 29 . However the underlying mechanism(s) attenuating TACV in humans is unclear. Glycoprotein-targeting subunit vaccines based on modified vaccine Ankara or Venezuelan equine encephalitis replicon vectored systems protect against lethal infection by JUNV in guinea pig models 30, 31 . However, because of heterogeneity in the glycoproteins 6, 28, 32 , it is unlikely these vaccines will provide sufficient cross-protection against heterologous arenaviruses. Thus, alternative strategies aimed at producing safe and broadly protective arenavirus vaccines are needed.
MACV strain Carvallo is the prototypical MACV strain first isolated in 1963 33, 34 . Several studies report that strain Carvallo is pathogenic in guinea pigs, with lethality upwards of 60% 28, 35 . We previously reported that a MACV strain Carvallo variant (Car 91 ) does not cause severe disease in guinea pigs 36 . Here, we found an earlier passage of strain Carvallo (Car 68 ) was virulent in guinea pigs. Subsequently, we identified genomic differences between virulent (Car 68 ) and avirulent (Car 91 ) Carvallo strains. Additionally, because Car 91 was apathogenic in guinea pigs, but produced detectable humoral immune responses, we investigated if it could function as a live-attenuated vaccine and protect against more distantly related NW arenaviruses. , this variant produced acute disease. As a control, one group of animals were infected with Chicava (Chic), a MACV strain known to cause lethal disease in this model 37 . Groups of eight animals were infected with the indicated strains and survival, weight and fever were monitored for 30 days (Fig. 1) . All animals infected with strain Chic begin to lose weight between days 8-20 (Fig. 1B) , but only one animal developed high fever ( > 41.0 °C) (Fig. 1C) . All Chic-infected animals succumbed to infection by day 24. Animals infected with Car 68 displayed weight loss between days 9-21, but none of the animals developed high fever ( > 41.0 °C). Car 68 also produced a lethal disease in guinea pigs; however three animals survived infection (~63% mortality rate). Distinct from Chic, three Car 68 infected animals developed paralysis starting with the hind-limb and were euthanized on day 21. The three surviving Car 68 infected animals began to rapidly increase in weight after a period of weight loss, and by day 30 they exceeded their starting weight by ~3-20%. The mean time to death (MTD) for Car 68 and Chic was 23.5 and 22 days, respectively. Confirming our earlier observations (SFig. 1), animals infected with Car 91 survived infection without displaying signs of disease (Fig. 1A) . Survival differences between Car 68 and Chic infected animals were not significant (logrank; p = 0.1331); however differences in survival between Car 91 versus Car 68 were highly significant (log-rank; p = 0.0082). Additionally, weight loss between Car 68 and Chic were significant compared to Car 91 for several days (Two-way ANOVA; p < 0.05). Viremia was detected in all four Chic-infected animals euthanized due to disease severity with GMT titers of 1,088 pfu/ml ( Fig. 2A) -challenged guinea pigs for the presence of binding and neutralization antibodies 30 days post-challenge. ELISA titers were determined using VSVΔG particles pseudotyped with glycoproteins from the MACV strain Carvallo as antigen. Six of eight guinea pigs had detectable antibodies against MACV glycoprotein with a log 10 GMT of 2.8 (Fig. 2B) . MACV neutralizing antibody was detected in all but two infected animals with PRNT50 and PRNT80 GMTs of 269 and 59.5, respectively (Fig. 2C) . The same two guinea pigs had no detectable PRNT50 or ELISA titers. Defective interfering (DI) particles are viral particles that carry mutations in the genome (typically deletions or rearrangements) that render the genome non-viable. During some infections, DI particles can accumulate to high levels through co-infection and disrupt the replication of viruses with viable genomes, leading to attenuation 39 . To examine whether a difference in the relative abundance of DI particles between Car 91 and Car 68 could be responsible for the attenuated phenotype of Car 91 , we examined the Illumina sequencing dataset in two ways. First, we looked for sequence coverage depth variation between the two isolates. Since DI particles often contain internal deletions, extreme levels of DI particles will skew sequencing coverage towards the ends of the genome fragments. Comparison of the patterns of sequence coverage depth between Car 68 and Car 91 did not reveal any obvious differences. For a more sensitive assay, we looked for evidence of chimeric reads, which would also be indicative of DI particle abundance. Chimeric reads are reads that span a deletion or rearrangement breakpoint, resulting in the 5′ and 3′ ends of the read aligning to non-adjacent regions of a reference genome. We detected 0.66% chimeric reads for Car 68 and 0.43% chimeric reads for Car 91 . Additionally, the pattern of deletions across the genome segments (by size and location) is similar between the two viruses (SFig. 3). Since the proportion of chimeric reads is higher in Car
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, indicating that Car 68 may actually have a higher proportion of DI particles, and the pattern of deletions across the genome is qualitatively similar, it is unlikely that DI particles are contributing to the attenuated phenotype of Car 91 . Altogether, these findings demonstrated that Car 91 has a significantly altered L-segment IGR relative to the earlier passaged Car 68 , including a 35 nt partial deletion. This disruption resulted in a predicted IGR structure with a ΔG value of −16.2 kcal/mol compared to −51.4 kcal/mol of Car 68 (Fig. 3C) . Thus, the Car 68 structure is predicted to be more thermodynamically stable compared to Car 91 by 3.2-fold. 
In vitro characterization of Car
91 , Car 68 and Chic. To begin to address the basis of the attenuation of Car 91 , we examined both Carvallo variants Car 91 and Car 68 , and strain Chic for differences in particle-to-pfu ratios and replication kinetics. Car 91 had the highest particle-to-pfu ratio with a geometric mean of 369, compared to Car 68 and Chic whose GMT ratios were 26 and 13, respectively (Fig. 4A ). These findings indicate that compared to Car 68 , Car 91 has a ~14-fold increase in the particle to pfu ratio. However, these differences were not statistically significant (T-test; p > 0.05).
The growth kinetics of both strain Carvallo variants and strain Chic were investigated in Vero cells, 104CL guinea pig fibroblasts and Human umbilical vein cells (HUVECs). Cells were infected with Car 91 , Car 68 or Chic and replication was assayed at 24, 48 and 72 h post-infection (hpi) (Fig. 4B) 
MACV strain Car
91 protects guinea pigs against lethal infection by GTOV. Because Car 91 was highly attenuated in guinea pigs but produced detectable immune responses in 10/12 guinea pigs (SFig. 1 and Fig. 4) , we hypothesized that it might function as an attenuated vaccine. Therefore, we examined the ability of Car 91 to protect guinea pigs against GTOV, a distantly related human pathogenic NW arenavirus species and causative agent of Venezuelan hemorrhagic fever 34, 40, 41 . Eight guinea pigs were challenged with GTOV 45 days after exposure to Car 91 (Fig. 5) . As a control for acute infection, a group of six weight-matched naïve guinea pigs were also infected with GTOV. Animals were monitored for survival, weight loss and fever over 25 days (Fig. 5A-C) . Consistent with previous findings 36, 41 , control animals began to lose weight starting around day 6 with concomitant fever. All control animals succumbed to infection with a MTD of 16 days. All but one animal The presence of binding antibody against MACV, JUNV and GTOV was evaluated by ELISA using sera from Car 91 -exposed (vaccinated) guinea pigs collected prior to and 30 days after GTOV challenge (Fig. 6A ). Prior to GTOV challenge, six of eight animals infected with MACV strain Car 91 had detectable antibodies against MACV with a log 10 GMT of 2.5. These responses increased following GTOV challenge to 3.6, but this increase was not significant (T-test; p = 0.1461). Antibody titers against GTOV prior to GTOV challenge were low or below detection. However, antibody titers against GTOV rose significantly (T-test; p = 0.0002) after GTOV challenge to a log 10 GMT of 2.5. Antibody titers against JUNV were also detected prior to GTOV challenge (log 10 GMT 2.0) in all but one animal and these responses significantly increased after GTOV challenge (T-test; p = 0.0242) with a log 10 GMT of 3.0. Animal#4, which succumbed to GTOV infection despite receiving Car 91 , had undetectable ELISA titers against MACV, GTOV and JUNV and an undetectable PRNT50 titer against MACV. Animal#1 survived GTOV challenge despite having no detectable humoral responses against GTOV and MACV, and a low response against JUNV ELISA antigen.
The PRNT titers against MACV significantly increased subsequent to GTOV challenge, with GMT PRNT80 titers rising from 59 to 320 (T-test; p = 0.0112) (Fig. 6B) . Despite the presence of MACV, GTOV and JUNV IgG antibody in all animals surviving GTOV challenge, we did not detect any neutralizing activity against GTOV or JUNV (Fig. 6C) . These findings demonstrated that guinea pigs inoculated with Car 91 are protected against heterologous challenge by GTOV. However, this protection occurred in the absence of detectable neutralizing antibody responses against the challenge virus.
Discussion
A major goal of arenavirus vaccine design is to develop a pan-arenavirus vaccine that protects against heterologous species within either the OW and NW complexes, or more broadly. Previous work has shown that JUNV, MACV and TACV can cross-protect against each other in animal models 24, 28 . However, we and others have found that JUNV and MACV to be much more serologically related (based on cross-neutralization and GP1 cross-binding) compared to GTOV 36 . Accordingly, to thoroughly gauge the level of heterologous protection against other NW arenaviruses, we purposely challenged Car 91 -vaccinated guinea pigs with the more genetically and serologically distant GTOV 36, 40 . We also delayed challenge for 45 days after the initial inoculation with Car 91 to avoid any transient innate immune effects that may have enhanced protection. The single animal succumbing to GTOV challenge failed to produce detectable antibodies against even MACV. We predict a higher dose (>10-fold) of Car 91 would have elicited more robust and protective immune responses and thus resulted in 100% protection. This prediction is based on the fact that the dose of the JUNV attenuated vaccine Candid#1 in humans is 40,000 pfu 20 , whereas here we used Car 91 at 1,000 pfu. Curiously, neutralizing antibody against GTOV was not detected in any animal even after GTOV challenge. Other studies demonstrate that TACV protects against JUNV infection in the absence of neutralizing antibody responses targeting the challenge virus 28 . These data support a model whereby non-neutralizing antibody and/or cytotoxic T-cell responses may play essential roles in protection against heterologous challenges. More work will be needed to fully address the correlates of protection however; our findings clearly indicate that attenuated MACV strains can produce cross-protective immune responses against distantly related arenaviruses at least within the same complex. While not tested in our study, it is likely Car 91 -inoculated animals would have been protected against challenge by a virulent strain of MACV (i.e. Car 68 or Chic). JUNV strain candid#1 protects against JUNV in infected animals, and this correlates with neutralizing antibody responses 21 . We previously reported that treatment of guinea pigs with anti-MACV neutralizing antibodies significantly reduces the humoral immune responses against Car 91 , suggesting the avirulent isolate had to replicate to some extent within infected animals to produce adequate immune responses 36 . This is supported by hematology data (SFig. 2) showing that the numbers of WBC/LEUKO are elevated over control animals two weeks after inoculation with Car 91 indicating an active immune response against the avirulent strain. Interestingly, WBC/LEUKO values after Car 68 (SFig. 2) and Chic (data not shown) exposure were similar to the controls, which is consistent with the ability of virulent strains of arenaviruses to cause suppression of the leukocyte responses 34 . Similarly, PLT values were also decreased for virulent strains consistent with the ability of arenaviruses to cause thrombocytopenia in infected hosts 34 . Importantly, Car 91 did not cause any apparent signs of disease such as weight loss or fever and LUC values of exposed animals, which are indicative of acute viral infections 38 , were not elevated, but were for the virulent Car 68 isolate. Arenavirus IGRs are situated between each encoded ORF on both L and S segments 8 , and play important roles in transcription and production of infectious progeny virions 42 . Mechanistically, IGRs fold into single or double stem-loop structures and are essential for transcription termination. Because the tertiary structure of the IGR is critical for mRNA transcription termination, modifications can significantly impact the efficiency of replication by disrupting protein synthesis. For example, truncation of the LUJV L-segment IGR produces a virus that replicates less efficiently in vitro due to inefficient gene transcription 43 . Our findings strongly suggest that spontaneous alteration of the L-segment IGR is chiefly responsible for the loss of virulence of the Car 91 variant in guinea pigs. High levels of DI particles in the Car 91 stock could also potentially cause attenuation, but examination of the sequencing data does not support the presence of higher levels of DI particles in the Car 91 stock compared to the Car 68 stock. The three silent mutations detected in the L protein open reading frame do not impact amino acid coding, making it unlikely they could contribute largely to attenuation. Thus, the only substantial difference between the avirulent Car 91 and virulent Car 68 is the L-segment IGRs. However, future studies using available MACV reverse genetic systems 44 will be needed to fully determine if the 35 nt partial IGR deletion alone is solely responsible for the attenuation.
It is unclear how a partial L-segment IGR deletion arose during passage of strain Carvallo. The available evidence indicates that Car 91 was passaged two additional times in VeroE6 cells compared to Car 68 . Some work has shown that MACV can be attenuated by cell culture passage 23 , but these studies did not report if attenuation involved IGR modification. Curiously Yun, et al., reported that the JUNV strain XJ was apathogenic in guinea pigs after additional passaging in mouse brains 45 . Other variants of XJ are known to be virulent in the guinea pig model [46] [47] [48] . It was not reported if this attenuation was the result of an IGR mutation or some other factor(s). The spontaneous loss of virulence of different mammalian arenaviruses as a result of propagation underscores the need to obtain sequencing data from clinical isolates as soon as they emerge to prevent the deleterious effects of cell culture or animal adaptation of the viral genome.
Car 91 had reduced replication fitness in vitro compared to Car 68 , including reduced replication in primary endothelial cells, which are in vivo targets of the virus 49 . However, these growth defects were relatively modest. Notably, the 1.5 log reduction in growth was similar to that observed for the LUJV containing the partial L-segment IGR deletion 43 . Whether the Car 91 replication deficiency alone results in the attenuation in vivo is not clear. It is possible that reduction in the size of the IGR and the resultant bearing on its tertiary structure may impact innate immune signaling pathways within infected cells, and this could play a critical role in attenuation. Hyperstimulation of the innate immune response as evidenced by interferon (IFN) stimulated gene expression has been observed in cell culture for attenuated JUNV vaccine strain Candid#1 50 . Future studies will be needed to fully elucidate the mechanism(s) by which partial IGR deletion produces apathogenic arenaviruses in vivo, with particular emphasis on activation of IFN stimulated gene products. Such analysis will benefit from the development of transcriptomic platforms specific to guinea pig gene expression ) prior to and after challenge with GTOV were determined as above. Note that PRNT80 titers prior to GTOV challenge are also depicted in Fig. 4C . (C) PRNT50 titers against JUNV, MACV and GTOV were determined as in Fig. 2 . Titers were determined as described above. The dashed line indicates the limit of detection. For all panels, asterisks denote statistical significance.
Scientific RepoRts | 7: 4679 | DOI:10.1038/s41598-017-04889-x swapping the IGRs of the L-and S-segments produces attenuated viruses that can protect mice against secondary challenge with wild-type LCMV 52, 53 . Our work indicates that modification of the L-segment IGR, including a 35 nt deletion, can also produce an attenuated virus that functions as a vaccine. Whether substitution of the IGR, incorporation of a synthetic IGR or deletion of the IGR is the best approach in live-attenuated arenavirus vaccine development remains to be determined. One advantage to deletion of multiple nucleotides is that reversion to wild-type is improbable. Work involving the arenavirus IGR as a vaccine strategy has focused exclusively on OW arenaviruses, specifically LCMV. Our study advances these vaccine strategies by supporting alteration of the IGRs as a powerful means of producing an attenuated live-virus vaccine against NW arenaviruses.
Many human pathogenic arenaviruses are endemic and well-described, such as LASV which causes >100,000 infections annually, in addition to several of the South American arenaviruses including JUNV, MACV and GTOV 54 . However, novel human pathogenic arenaviruses emerge at unpredictable rates in both the Americas and Africa 2, [13] [14] [15] [16] 55 , the most recent being Lujo virus in Africa. Accordingly, any vaccine-based countermeasure should be designed to protect broadly protect against known and unknown arenaviruses. Our work and the work of others 52, 53 support the use of IGR-modification as a strategy for pan-arenavirus vaccine development. With the advent of arenavirus reverse genetics 56 , other attenuation strategies such as codon deoptimization 57, 58 could be combined with IGR-modification to produce rationally-designed vaccines that are both highly-attenuated, yet replication competent and safe for human use. ) were propagated as previously reported 36 . All viruses were twice plaque purified prior to use. Car 68 was passaged twice in sucking hamster brains and once in VeroE6 cells. Car 91 was passaged an addition two times in VeroE6 cells. 239 T cells and 104CL guinea pig fibroblasts (ATCC) were maintained in MEM or RPMI containing 10% heat-inactivated fetal bovine serum (FBS), 1% antibiotics (100 U/ml penicillin, 100 μg/ml of streptomycin, respectively. HUVECs were purchased from a commercial source (Lonza) and maintained in endothelial growth medium.
Challenge of Hartley guinea pigs. Female Hartley guinea pigs (300-400 g) were implanted with IPTT-3000 identification chips to monitor temperature (BMDS INC; Seaford, DE). Animals were challenged with the indicated MACV strains (1,000 pfu) or GTOV (2,000 pfu) diluted in a total volume of 0.5 ml PBS by intraperitoneal (i.p.) injection. Animals were weighed and monitored for fever. All animal studies were conducted in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adheres to principles state in the Guide for the Care and Use of Laboratory Animals, National Research Council 59 . All animal experimental protocols were approved by a standing internal institutional animal care and use committee (IACUC). The facilities where this research was conducted are fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International. Animals meeting criteria were humanly euthanized.
Plaque reduction and neutralization tests (PRNTs).
PRNTs were performed as previously described 60 using guinea pig serum serially diluted two-fold starting at 1:40. Percent neutralization was calculated relative to the number of plaques in the presence of negative control serum. Titers represent the reciprocal of the highest dilution resulting in a 50% reduction in the number of plaques. Data were plotted using Graphpad Prism software.
Growth kinetics. Vero, 104CL and HUVECs were seeded at a density of 1 eql × 10 5 cells per well in 24-well plates and infected at an MOI of 0.1 with the indicated viruses diluted in culture medium. Virus growth at 24, 48 and 72 h was determined by plaque assay on Vero cell monolayers. All samples were run in two independent replicates and plotted as the mean + / − standard deviation (SD) using Graphpad Prism software.
Particle-to-PFU ratio. Particle counts were determined with a Virocyt machine (Virocyt, Boulder, CO) using the manufacture's protocol. The particle-to-pfu ratios were determined by dividing particle counts by the amount of infectious virus. Four independent virus preparations per strain were used in the calculations.
Genome sequencing. RNA was extracted from Trizol homogenates of MACV, converted to cDNA, and subjected to sequence-independent, single primer amplification (SISPA) 61 . The products of these reactions were used to generate libraries that were sequenced on an Illumina MiSeq. Sequencing reads were assembled using DNAStar SeqMan NGen. Predicted secondary structures of the IGRs were determined using DNAstar Genequest.
Identification of defective genomes. To look for putatively defective vNiral genomes (i.e., genomes with large deletions or rearrangements), we identified chimeric reads from the Illumina dataset. Chimeric reads were defined as reads with 1) two distinct, non-overlapping alignments to different regions of the MACV genome and with 2) ≥99% of read bases aligned to the reference when considering both alignments together. To prevent bleed through between multiplexed samples, we used non-overlapping dual indexes and we filtered out any reads with index base qualities less than Phred 20, on average. Only the first read from each pair was used to avoid double counting. Illumina and SISPA adaptors were clipped using Cutadapt v1.9.dev1 62 and Prinseq-lite v0.20.3 63 was used to 1) remove 6 nt from the beginning and end of each read ("-trim_right 6 -trim_left 6"; to remove random hexamers), 2) trim low quality bases from the 3′ ends of the reads ("-trim_qual_right 30 -trim_qual_type min -trim_qual_window 5"), 3) remove reads <40nt in length or with a mean quality score less than Phred 20 ("-min_len 40 -min_qual_mean 20"), 4) remove reads with low complexity ("-lc_method dust -lc_threshold 3") and 5) remove exact duplicates ("-derep 14"). Reads were then aligned to a reference sequence (Car 68 GenBank:
Scientific RepoRts | 7: 4679 | DOI:10.1038/s41598-017-04889-x KM198592.1 and KM198593.1; Car 91 sequences have been uploaded to GenBank) using BWA mem v.0.7.12 with default parameters 64 . Chimeric reads were identified and characterized using a custom script, chimeric_reads. py v3.5.4 (https://github.com/jtladner/Scripts/tree/master/chimeric_reads). Note that the S-segment consensus sequence for Car 91 exactly matches that of Car 68 (KM198592.1).
Pseudovirion neutralization assay (PsVNA) and ELISA. The pseudovirion neutralization assay (PsVNA) has been described in detail elsewhere 36, 65 . Briefly, a vesicular stomatitis virus backbone with a luciferase reporter gene (PsV) was used to produce particles decorated with glycoproteins from MACV, JUNV and GTOV. These particles were subsequently incubated with the indicated serially diluted sera in triplicate and the geometric mean PsVNA80 titers (GMT) plotted. The use of PsV as solid phase antigen in ELISAs has been previously described in detail 36 .
Statistical analysis. Two-way ANOVA with the Bonferroni correction was used to analyze both weight and viral replication (in vitro). Log-rank test was performed for statistical analysis of survival. The statistical significance of PRNTs was determined using an unpaired two-tailed Student's t test. Significance levels were set at a p value less than 0.05. All analyses were performed using Prism software.
Data Availability. All data generated or analyzed during this study are included in this published article (and its Supplementary Information files) with the exception of the genomic data for Car 91 . The sequencing information for Car 91 has been uploaded to Genbank.
